The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Pandemic Preparedness and Response — Lessons from the H1N1 Influenza of 2009
Open accessAbstract
A number of viruses have pandemic potential.For example, the coronavirus responsible for the severe acute respiratory syndrome (SARS), which first appeared in southern China in November 2002, caused 8096 cases and 774 deaths in 26 countries before coming to a halt by July 2003 mainly owing to isolation and quarantine. 1 In terms of persistence, versatility, potential severity, and speed of spread, however, few viruses rival influenza virus.Endemic in a number of species, including humans, birds, and pigs, influenza virus causes annual outbreaks punctuated by occasional worldwide pandemics, which are characterized by sustained community spread in multiple regions of the world.Beyond spread, the degree to which a pandemic is defined according to the severity of the disease, or whether it may be simply described as often producing many illnesses and deaths, remains ambiguous.2 At its worst, pandemic influenza can be catastrophic: the great influenza pandemic of 1918-1919 is estimated to have infected 500 million persons worldwide and to have killed 50 to 100 million persons. 3 In a typical year of seasonal outbreaks in the Northern and Southern Hemispheres, influenza virus causes as many as 5 million cases of severe illness in humans and 500,000 deaths.4 Over the past decade, sporadic cases of severe influenza and deaths in humans have been caused by a number of avian influenza A viruses, including the H5N1 virus, first detected in 1997, and the H7N9 and H10N8 viruses, first reported in 2013.Such sporadic cases may be harbingers of a gathering pandemic, but the likelihood is difficult to judge because it is not known how frequently similar zoonotic episodes occurred silently in the past, when surveillance was more limited, and did not cause pandemics.The most recent global pandemic was caused by the influenza A (H1N1) strain, which was first detected in North America in 2009 (influenza A[H1N1]pdm09).This event prompted the first activation of provisions under the 2005 International Health Regulations (IHR), which went into effect in 2007.5 Deliberations that led to the 2005 IHR revisions were shaped by experience in the SARS outbreak of 2003.The regulations delineate the responsibilities of individual countries and the leadership role of the World Health Organization (WHO) in declaring and managing a public health emergency of international concern.The 2009 H1N1 pandemic presented a public health emergency of uncertain scope, duration, and effect.The experience exposed strengths of the newly implemented IHR as well as a number of deficiencies and defects, including vulnerabilities in global, national, and local public health capacities; limitations of scientific knowledge; difficulties in decision making under conditions of uncertainty; complexities in international cooperation; and challenges in communication among experts, policymakers, and the public.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
Osterholm, M. T., Kelley, N. S., Sommer, A., & Belongia, E. A. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70295-x · Cited by 1,789
1918 Influenza: the Mother of All Pandemics
Taubenberger, J. K., & Morens, D. M. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1201.050979 · Cited by 1,686
Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets
Herfst, S., Schrauwen, E. J. A., Linster, M., Chutinimitkul, S., de Wit, E., Munster, V. J., Sorrell, E. M., Bestebroer, T. M., Burke, D. F., Smith, D. J., et al. (2012) · Science · doi:10.1126/science.1213362 · Cited by 1,665
1918 Influenza: the Mother of All Pandemics
Taubenberger, J. K., & Morens, D. M. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1209.05-0979 · Cited by 1,590
Imai, M., Watanabe, T., Hatta, M., Das, S. C., Ozawa, M., Shinya, K., Zhong, G., Hanson, A., Katsura, H., Watanabe, S., et al. (2012) · Nature · doi:10.1038/nature10831 · Cited by 1,523
Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada
Kumar, A. (2009) · JAMA · doi:10.1001/jama.2009.1496 · Cited by 1,425
Dawood, F. S., Iuliano, A. D., Reed, C., Meltzer, M. I., Shay, D. K., Cheng, P.-Y., Bandaranayake, D., Breiman, R. F., Brooks, W. A., Buchy, P., et al. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70121-4 · Cited by 1,363
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
Kanekiyo, M., Wei, C.-J., Yassine, H. M., McTamney, P. M., Boyington, J. C., Whittle, J. R. R., Rao, S. S., Kong, W.-P., Wang, L., & Nabel, G. J. (2013) · Nature · doi:10.1038/nature12202 · Cited by 885
Critically Ill patients with 2009 influenza A(H1N1) in Mexico
Domínguez-Cherit, G. (2009) · JAMA · doi:10.1001/jama.2009.1536 · Cited by 840
Digital disease detection - harnessing the Web for public health surveillance
Brownstein, J. S., Freifeld, C. C., & Madoff, L. C. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0900702 · Cited by 819
Global Mortality Estimates for the 2009 Influenza Pandemic from the GLaMOR Project: A Modeling Study
Simonsen, L., Spreeuwenberg, P., Lustig, R., Taylor, R. J., Fleming, D. M., Kroneman, M., Van Kerkhove, M. D., Mounts, A. W., Paget, W. J., & Teams, T. G. C. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001558 · Cited by 485
International Health Regulations
(1971) · Royal Society of Health Journal · doi:10.1177/146642407109100301 · Cited by 431
Influenza Vaccine — Outmaneuvering Antigenic Shift and Drift
Treanor, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmp038238 · Cited by 259
Viboud, C., Miller, M., Olson, D. R., Osterholm, M., & Simonsen, L. (2010) · PLoS Currents · doi:10.1371/currents.rrn1153 · Cited by 216
The elusive definition of pandemic influenza
Doshi, P. (2011) · Bulletin of the World Health Organization · doi:10.2471/blt.11.086173 · Cited by 188
How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count
Lipsitch, M., Hayden, F. G., Cowling, B. J., & Leung, G. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61377-5 · Cited by 94
The epidemic that never was : policy-making and the swine flu scare
Neustadt, R. E., Fineberg, H. V., & Hamburg, D. A. (1983) · DigitalGeorgetown (Georgetown University Library) · Cited by 57
Self-citation
Cited by
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
Petersen, E., Koopmans, M., Go, U., Hamer, D. H., Petrosillo, N., Castelli, F., Storgaard, M., Al Khalili, S., & Simonsen, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30484-9 · Cited by 1,205
Allcott, H., Boxell, L., Conway, J., Gentzkow, M., Thaler, M., & Yang, D. (2020) · Journal of Public Economics · doi:10.1016/j.jpubeco.2020.104254 · Cited by 999
Otter, J. A., Donskey, C., Yezli, S., Douthwaite, S., Goldenberg, S. D., & Weber, D. J. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2015.08.027 · Cited by 780
mRNA-based therapeutics: powerful and versatile tools to combat diseases
Qin, S., Tang, X., Chen, Y., Chen, K., Fan, N., Xiao, W., Zheng, Q., Li, G., Teng, Y., Wu, M., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01007-w · Cited by 771
Jusup, M., Holme, P., Kanazawa, K., Takayasu, M., Romić, I., Wang, Z., Geček, S., Lipić, T., Podobnik, B., Wang, L., et al. (2022) · Physics Reports · doi:10.1016/j.physrep.2021.10.005 · Cited by 643
Metadata
- Authors
- Fineberg, H. V.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-04-03
- Volume
- 370
- Issue
- 14
- Pages
- 1335-1342
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2120350078
- Cited by
- 562
- References
- 18
- FWCI
- 26.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.